Ten-year survival data show long-term benefit of immunotherapy in melanoma
BioPharma Drive: Drug Pricing
SEPTEMBER 15, 2024
Final follow-up results suggest Opdivo and Yervoy could be close to a cure for some people with advanced melanoma, shifting how doctors administer follow-up care.
Let's personalize your content